Scientists Bridge Gap In Cell Communication

July 16, 1997

A critical step in communication between cells that promotes such things as bone formation, limb growth, and the development of other critical tissues, has been found by a team of researchers from the University of Wisconsin-Madison.

The discovery, reported today (July 17) in the British scientific journal Nature, while fundamental in nature, is important because it adds an essential strand of information to scientists' understanding of how cells relay molecular messages, a process that, if disrupted, can result in cancer and defects in embryonic development.

By revealing the terminus of the pathway by which cells send and receive messages, the find promises a rational basis for the future treatment of some diseases and, more immediately, gives science a new grasp of a process that triggers decisive events in cells.

Studying a well-known signaling protein called MAD, UW-Madison geneticist Allen Laughon and colleagues determined that the protein is responsible for switching genes on or off by binding directly to DNA, in effect telling the cell to start or stop a specified task.

It closes the loop, said Laughon, whose work was accomplished in fruit flies taking advantage of the well-studied process by which signaling governs wing growth. "We've shown that the MAD protein is a direct regulator of target gene transcription in response to a (specific) signal."

The mapping of the communication pathways between cells is a fundamental quest in modern biology. Identifying the messengers -- a large family of proteins that carry genetic signals and switch genes on and off -- and their roles in communicating at a distance has implications for the development of new strategies to treat diseases caused by malfunctioning genes or disrupted pathways of communication.

Communication -- or miscommunication -- between cells is the basis for many diseases. For example, in humans it is believed that there are many layers of genes which act as a group to prevent cancer by blocking the inappropriate proliferation of cells. But if these "tumor suppression genes" are defective, cells become blind to messages meant to ward off runaway cell proliferation. The result can be cancer.

"As long as cells sense this information, they don't grow out of control," Laughon said.

Now, having revealed the last leg of the communications pathway, the Wisconsin scientists have opened a window on the very root of genetically-mediated diseases like some cancers.

"We've found a mechanism that is really important," said Sean Carroll, a co-author of the study and a molecular biologist at the Howard Hughes Medical Institute at UW-Madison. "The universe of genes regulated by this pathway is very large. I would guess hundreds of genes."

"The missing link," explained Laughon, "has been how the signal switches genes on or off. This protein shuttles from the inner surface of the cell membrane right to the DNA, in one fell swoop."

The discovery, Laughon emphasized, will have no immediate medical application, but may lead to the development of new genetic-based treatments for disease. It also reveals that the pathway from cell surface to the gene is remarkably direct.

CONTACTS: Allen Laughon, (608) 262-2456,; Sean Carroll, (608) 262-6191,

University of Wisconsin-Madison

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to